Therapeutic benefits of budesonide in gastroenterology

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

(2010) A. Dignass et al.   Journal of Crohns & Colitis

Budesonide Is Effective in Treating Lymphocytic Colitis: A Randomized Double-Blind Placebo-Controlled Study

(2009) Stephan Miehlke et al.   GASTROENTEROLOGY

Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon

(2009) Michael Wagner et al.   INFLAMMATORY BOWEL DISEASES

Oral budesonide for maintenance of remission of Crohn’s disease: a pooled safety analysis

(2008) G. R. LICHTENSTEIN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Interventions for Treating Microscopic Colitis: A Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group Systematic Review of Randomized Trials

(2008) Nilesh Chande et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Oral Budesonide for Maintenance Treatment of Collagenous Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Stephan Miehlke et al.   GASTROENTEROLOGY

Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial

(2008) O K Bonderup et al.   GUT

Azathioprine Is Superior to Budesonide in Achieving and Maintaining Mucosal Healing and Histologic Remission in Steroid-Dependent Crohnʼs Disease

(2008) Gerassimos J. Mantzaris et al.   INFLAMMATORY BOWEL DISEASES